Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | CA3 | P07451 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | CES1 | P23141 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | KCNN4 | O15554 | 6/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL30260008 | 0.85 | CA12 (0.58) | TDP1CA12CA1CA2GLA | |
| Trifluoroacetic Acid SCHEMBL5776611 | 0.85 | CA12 (0.58) | TDP1CA12CA1CA2GLA | |
| Trifluoroacetic Acid SCHEMBL25326318 | 0.85 | CA12 (0.58) | TDP1CA12CA1CA2GLA | |
| Trifluoroacetic Acid SCHEMBL466686 | 0.85 | CA12 (0.58) | TDP1CA12CA1CA2GLA | |
| Phenol SCHEMBL81020 | 0.83 | CA12 (0.55) | TDP1CA12CA1CA2GLA | |
| Phenol SCHEMBL27815365 | 0.83 | CA12 (0.55) | TDP1CA12CA1CA2GLA | |
| Phenol SCHEMBL4258503 | 0.82 | CA2 (0.69) | TDP1CA12CA1CA2GLA | |
| Phenol SCHEMBL28505932 | 0.82 | CA2 (0.69) | TDP1CA12CA1CA2GLA | |
| Phenol SCHEMBL1448002 | 0.82 | CA2 (0.69) | TDP1CA12CA1CA2GLA | |
| Phenol SCHEMBL166786 | 0.82 | CA2 (0.69) | TDP1CA12CA1CA2GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106986992-B | A kind of benzoxazoles resin and its method | 江苏大学 | 2019-06-28 | — | — | CN | claimed |
| CN-106986992-A | A kind of benzoxazole resin and its method | 江苏大学 | 2017-07-28 | — | — | CN | claimed |
| CN-112341584-B | Bio-based benzoxazine resin containing furan amide structure and preparation method thereof | 四川轻化工大学 | 2023-09-08 | — | — | CN | disclosed |
| CN-112341584-A | Bio-based benzoxazine resin containing furan amide structure and preparation method thereof | 四川轻化工大学 | 2021-02-09 | — | — | CN | disclosed |
| CN-106986992-B | A kind of benzoxazoles resin and its method | 江苏大学 | 2019-06-28 | — | — | CN | disclosed |
| CN-106986992-B | A kind of benzoxazoles resin and its method | 江苏大学 | 2019-06-28 | — | — | CN | disclosed |
| CN-106986992-A | A kind of benzoxazole resin and its method | 江苏大学 | 2017-07-28 | — | — | CN | disclosed |
| CN-106986992-A | A kind of benzoxazole resin and its method | 江苏大学 | 2017-07-28 | — | — | CN | disclosed |
| EP-1641745-B1 | PROPIONAMIDE DERIVATIVES USEFUL AS ANDROGEN RECEPTOR MODULATORS | ORION CORP (FI) | 2010-04-14 | — | — | EP | disclosed |
| US-7390923-B2 | Propionamide derivatives useful as androgen receptor modulators | ORION CORPORATION (FI) | 2008-06-24 | — | — | US | disclosed |
| US-20070123512-A1 | Propionamide derivatives useful as androgen receptor modulators | ORION CORPORATION (FI) | 2007-05-31 | — | — | US | disclosed |
| EP-1641745-A1 | PROPIONAMIDE DERIVATIVES USEFUL AS ANDROGEN RECEPTOR MODULATORS | Orion Corporation (FI) | 2006-04-05 | — | — | EP | disclosed |
| WO-2005000794-A1 | PROPIONAMIDE DERIVATIVES USEFUL AS ANDROGEN RECEPTOR MODULATORS | ORION CORPORATION (FI) | 2005-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070123512-A1 | Propionamide derivatives useful as androgen receptor modulators | NR5A1, FSHR, GNRHR | TDP1 1617/4885CA12 4313/4885CA1 3638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.